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Taming \Rogue" Pharmacy Websites: The Response to Illegal
Prescription Drug Sales on the Internet
Michael Downs
\Two inexorable forces of the 1990s { the growth of the Internet and rapid
rise of prescription drug use { appear to be on a collision course."1
\
The fact is, there a number of sites that are practicing illegally and need to
be shut down."2
I.
Introduction
What has emerged from recent media coverage,3 White House statements,4
1Francine Kiefer, Online Pharmacies Draw Federal Scrutiny: The Clinton Administration
Proposes Rules to Prevent Internet Drug Sale, Christian Sci. Monitor, Dec. 29, 1999.
2Chris Adams, Plan to Curb Drugstores on Web Is Hit, Wall St. J., Dec. 29, 1999
(quoting Carmen Catizone, Executive Director of the National Association of Boards of Phar-
macy).
3See generally Anne Veigle, Web-based Pharmacies Can Pose Health Hazards, Wash.
Times, Apr. 4, 2000; Christine Gorman, The Web Docs: The Internet Can Fill the Gaps
in Your Medical Knowledge. But You Need to Know How to Separate the Good Sites From
the Bad, Time, Apr. 3, 2000; Lucette Lagnado, Laetrile Makes a Comeback on the Web,
Wall St. J., Mar. 22, 2000; Mary Hickey, The Virtual Pharmacy: Be Careful When
You Click, Bus. Wk., Mar. 20, 2000; Virginia Postrel, Prescription for Trouble, Reason,
Mar. 1, 2000 (reporting that online pharmacies challenge traditional medical models and the
regulatory backlash threatens broader Internet freedoms); John Henkel, Buying Drugs Online:
It's Convenient and Private, But Beware of `Rogue Sites', FDA Consumer, Jan. 1, 2000.
4President's Working Group on Unlawful Conduct on the Internet, The Electronic Frontier:
The Challenge of Unlawful Conduct Involving the Use of the Internet (last modied April
4, 2000) <http://www.usdoj.gov/criminal/cybercrime/unlawful.htm> [hereinafter Working
Group Report]; Exec. Order No. 13,133, 64 FR 43,895 (1999).
1and congressional hearings5 is a fairly clear picture of the threat to public health
posed by \rogue" online pharmacies and the obstacles facing state and federal
agencies in regulating them. Exactly who should be regulating online phar-
macies and what, if any, additional legislation is necessary is less clear. Several
dierent courses of actions have been proposed to address the almost universally
perceived threats to public health and the privacy of consumer information.6
What is very clear is that nobody is certain how to address the fact that many
of these \rogue" online pharmacies are based in foreign countries, and this is
cause for serious concern.7
The following discussion provides an overview of how online pharmacies op-
erate and what potential risks they pose to public health. It also outlines the
laws and authorities that regulate online pharmacies, the obstacles to enforc-
ing existing laws, and recent actions taken against \rogue" websites. Finally,
it oers an overview of several dierent recent proposals designed to meet the
challenges of online pharmacies.
II.
Background
5Hearing on E-Drugs: Who Regulates Internet Pharmacies? Before the Senate Comm.
on Health, Education, Labor and Pensions, 106th Cong., March 21, 2000 [hereinafter Senate
HELP Hearing]; Hearing on Drugstores on the Net: The Benets and Risks of On-line
Pharmacies Before the Subcomm. On Oversight and Investigations of the H.R. Com. Comm.,
106th Cong., July 30, 1999 [hereinafter House Oversight Hearing].
6See, e.g., Working Group Report, supra note 4.
7See, e.g., Adams, supra note 2.
2A.
Rapid growth of online pharmaceutical sales
The oering of pharmaceutical products for sale through the Internet is a
relatively recent phenomenon. With health care costs on the increase, more
consumers are turning to the Internet as a source of health information and as a
lower cost source for pharmaceutical products.8 According to one recent survey,
health concerns are the sixth most common reason people use the Internet.9 As
a result, during 1999 online pharmacies did more than $1.9 billion of business
in health and beauty products, including prescription drugs, over-the-counter-
drugs, vitamins, and toiletries.10 The number of prescriptions being lled online
is growing rapidly.11
B.
Benets of online pharmacies
The benets of having online pharmacies provide prescription drugs include
the convenience and privacy of home delivery and access for those who cannot
or choose not to go to a traditional, \brick-and-mortar" pharmacy.12 Websites
also oer health information, buying guides, and direct access to pharmacists.13
8A 1999 survey by Consumer Reports found that buyers may save up to 29 percent by
purchasing certain drugs online. Henkel, supra note 3.
9Id.(citing study by Cyber Dialogue Inc.).
10See, e.g., Working Group Report, supra note 4, at Appendix D.
11In the rst two months of its operation, Walgreen Inc.'s Internet pharmacy grew to dis-
pensing 2,000 prescriptions per day. Bruce Japsen, Clinton Gets Praise for Web Drug Curb
Plan, Chicago Tribune, Dec. 29, 1999.
12See, e.g., Working Group Report, supra note 4, at Appendix D.
13Senate HELP Hearing, supra note 5 (statement of Jane E. Henney, Food and Drug Ad-
ministration Commissioner). See also Senate HELP Hearing, supra note 5 (statement of Peter
Neupert, chief executive ocer of drugstore.com).
3Customers may also nd lower prices at online pharmacies as a result of price
competition among online businesses.14 It has also been suggested that on-
line pharmacies may help to reduce prescribing errors commonly attributed to
poor handwriting and interpretation skills because the prescribing information
is transmitted electronically.15
C.
The trouble with online pharmacies
Some of the websites operating as online pharmacies are cyberspace spin-
os of major American drugstore chains. Others began their businesses online
and have already established themselves as legitimate Internet brand names.16
However, there are many reports of illegitimate domestic and foreign (often
appearing to be American-based companies) \rogue" websites that oer low-
priced prescription drugs which may be unapproved, counterfeit, contaminated,
mislabeled, manufactured in unapproved facilities, or handled improperly.17
While there have been consumer complaints about these \rogue" websites,
with one notable exception18 there have been few if any serious injuries re-
ported.19 Nonetheless, the most egregious reported cases make apparent the
14See, e.g., Senate HELP Hearing, supra note 5 (statement of Senator James M. Jeords).
15Senate HELP Hearing, supra note 5 (statement of Jane E. Henney, Food and Drug Ad-
ministration Commissioner).
16For example, CVS, a well-established drugstore chain, has a pharmacy website at
CVS.com. In contrast, drugstore.com started its business in 1999 and only operates in cy-
berspace. See Senate HELP Hearing, supra note 5 (statement of Peter Neupert, chief execu-
tive ocer of drugstore.com).
17Senate HELP Hearing, supra note 5 (statement of Senator James M. Jeords).
18There was one report of a 52-year-old man with a history of heart disease and episodes
of chest pain who died of a heart attack after buying Viagra from an online pharmacy that
required only answers to a questionnaire to be approved for the prescription. See Henkel,
supra note 3 (noting that there is no proof linking the man's death to the use of the drug).
19But consumers suering injuries may be afraid to self-report. Senate HELP Hearing,
4serious threat to public health posed by these \rogue" websites.20
In fact, there are only six websites, each requiring a valid physicians' pre-
scription before dispensing prescription medications, that the National Associ-
ation of Attorneys General (\NAAG") considers legitimate.21 There are over
400 other controversial websites that oer online consultations with a prescriber
who then approves the dispensation of desired prescription drugs.22
The very strengths of Internet technology, including anonymity, speed, and the
ability for communications to cross state and international borders, have thus
created risks to public health.23 Suspect websites also present serious challenges
to law enforcement because often they are \y-by-night operations" and \expert
at evading detection."24
Finally, there is \troubling evidence that some health websites may be failing
to safeguard the privacy of their customers' sensitive medical information" and
in some cases may even be selling consumer information.25
While these \rogue" online pharmacies are cause for concern, most commenta-
supra note 5 (statement of Calvin A. Anthony, executive vice president of National Community
Pharmacists Association).
20In one instance, a journalist received Viagra even after her response to an online ques-
tionnaire indicated that she had been \neutered" as the result of a prior surgery. Another
journalist was able to acquire a diet drug after indicating on a questionnaire that she weighed
only 97 pounds. In a sting conducted by the Kansas Attorney General's Oce, a 16-year-
old boy ordered and received Viagra from a website using a credit card in his mother's name.
Senate HELP Hearing, supra note 5 (statement of Carla J. Stovall, Kansas Attorney General).
21Id.
22The Senate Health, Education, Labor, and Pension Committee has received hundreds
of reports of Internet pharmacies selling prescription drugs on the basis of answers given to
an online health questionnaire and without proof of a physical examination. The American
Medical Association has condemned such operations as unethical. Senate HELP Hearing,
supra note 5 (statement of Senator Christopher J. Dodd).
23Senate HELP Hearing, supra note 5 (statement of Jane E. Henney, Food and Drug Ad-
ministration Commissioner).
24Adams, supra note 2.
25Senate HELP Hearing, supra note 5 (statement of Senator Christopher J. Dodd).
5tors are also sure to note that any plan to combat the illegal sale of prescription
drugs online should not disrupt the societal benets of online pharmacies and
electronic commerce in general.26
III.
Overview of online pharmacies
The websites oering prescription drugs for sale over the Internet may be
separated into three distinct categories. The rst category includes online phar-
macies that operate like traditional \brick-and-mortar" pharmacies or \legiti-
mate" mail-order pharmacies.27 This category includes websites that are the
online presence of an established pharmacy chain28 or are relative newcomers
that started business in cyberspace.29 Such pharmacies are licensed in each of
the states to which they dispense medications and also require that their phar-
macists are state-licensed.30 In addition, these pharmacies only ll prescriptions
obtained previously by their customers from licensed physicians or transferred
from another pharmacy. In either case, these websites attempt to verify the le-
gitimacy of the prescription before lling the order.31 These online pharmacies
also typically oer a phone number that consumers can call with questions, and
26See, e.g., Working Group Report, supra note 4.
27Id. Working Group Report, at Appendix D.
28Such a website may be thought of as a \logical extension" of a traditional \brick-and-
mortar" or legitimate mail order pharmacy. Senate HELP Hearing, supra note 5 (statement
of Janet Woodcock, Director of the Center for Drug Evaluation and Research of the Food and
Drug Administration).
29For example, drugstore.com, which conducts its pharmacy business exclusively through
the Internet, was established in 1999. Senate HELP Hearing, supra note 5 (statement of
Peter Neupert, chief executive ocer of drugstore.com).
30See, e.g. Working Group Report, supra note 4, at Appendix D; Japsen, supra note 11
(\Legitimate on-line rms like Drugstore.com Inc. and Planet Rx.com Inc. have state licenses
and legitimate contracts with both distributors and drugmakers.").
31Senate HELP Hearing, supra note 5 (statement of Peter Neupert, chief executive ocer
of drugstore.com).
6some oer health information such as advice on drug interactions.32
These websites should indicate their licensure in all the states in which they
operate, and provide proles and licensure information for their pharmacists.
In short, these websites provide \services you would expect to get from your
traditional pharmacy."33
Online pharmacies of this type thus conduct business in a manner that suggests
compliance with a comprehensive regulatory scheme that includes pre-market
approvals, prescription drug designations, practitioner examinations, and phar-
macy dispensing.34 Accordingly, this traditional regulatory scheme of state and
federal laws constitutes \a safety net to protect the American public from in-
juries resulting from unsafe drugs, counterfeit drugs, and improper prescribing
and dispensing practices."35
A second and more controversial category of online pharmacies consists of web-
sites that both \prescribe" and dispense prescription medications.36 These web-
sites do not require that a customer already have a legitimate prescription from
a licensed physician. Instead, the websites require an online \consultation" be-
fore dispensing drugs.37 The customer-patient is asked to ll out and submit
32Senate HELP Hearing, supra note 5 (statement of Janet Woodcock, Director of the Center
for Drug Evaluation and Research of the Food and Drug Administration).
33Senate HELP Hearing, supra note 5 (statement of Janet Woodcock, Director of the Center
for Drug Evaluation and Research of the Food and Drug Administration).
34See Working Group Report, supra note 4, at Appendix D; Senate HELP Hearing,
supra note 5 (statement of Jane E. Henney, Food and Drug Administration Commissioner).
35Working Group Report, supra note 4.
36See, e.g., Senate HELP Hearing, supra note 5 (statement of Jane E. Henney, Food and
Drug Administration Commissioner).
37But often the process is not very rigorous: \[A]ll you have to do is answer a questionnaire
and give them your credit card number." Senate HELP Hearing, supra note 5 (statement of
Janet Woodcock, Director of the Center for Drug Evaluation and Research of the Food and
Drug Administration).
7an online questionnaire, specifying medical history, symptoms, and any current
medications.38 A prescriber associated with the online pharmacy then sup-
posedly reviews the medical information and approves the desired medication if
appropriate.39 Typically, there is a charge for this consultation. Once approved,
the pharmacy lls the prescription and ships the product to the customer.40
The questionnaires at dierent websites of this type may vary in the amount and
types of information they require, but most ask for information about known al-
lergies, current medical conditions, and current medications.41 However, many
of these sites also provide defaulted or highlighted answers to the medical ques-
tions on the online forms, answers that would support a prescription being
issued.42 One of the more obvious risks in using such a website is \you have
no idea whether there's a doctor in cyberspace who will be evaluating the ques-
tionnaire, and you will certainly have no idea of the quality of that doctor."43
The third category of online pharmacy includes those that dispense prescription
drugs without requiring a prescription or online consultation.44 Such websites
38Working Group Report, supra note 4, at Appendix D.
39See Senate HELP Hearing, supra note 5; Naftali Bendavid, Plan to Regulate Over-the-
Web Drug Sales Draws Fire: Clinton Wants the FDA to Monitor Internet Pharmacies, But
Some Wonder If the Agency Is Right for the Job, Chicago Tribune, Dec. 29, 1999 (\An
estimated 400 Internet sites oer drugs without requiring a prescription from the patient's
physician. Many of these sites have hired doctors who are willing to bend their profession's
rules by writing prescriptions for on-line shoppers without face-to-face contact."). See also
Kiefer, supra note 1.
40Working Group Report, supra note 4.
41Senate HELP Hearing, supra note 5 (statement of Janet Woodcock, Director of the Center
for Drug Evaluation and Research of the Food and Drug Administration).
42Id.
43Id. Furthermore, if a patient experiences some side eects after taking the medication,
there is typically no health care practitioner he can call with questions or concerns: \[Y]our
only recourse is to send the site an e-mail and hope that they respond. It may be that the
web site is actually not located within a pharmacy. It may just be a conduit for drug sales.
It may take quite a while for a knowledgeable person to contact you , if one ever does." Id.
44For the purposes of this discussion, these websites will be referred to as \online pharma-
cies" although they do not require a prescription. See, e.g., Senate HELP Hearing, supra note
5 (statement of Jane E. Henney, Food and Drug Administration Commissioner) (noting that
8may oer products making fraudulent health claims, drugs for recreational use,
or unapproved drugs.45 These websites are clearly in violation of state and
federal laws regarding the dispensing of prescription medications.
IV.
Risks of \rogue" websites
A.
The threat to public health
Websites that provide online consultations or issue prescription drugs with-
out requiring prescriptions at all are the focus of the proposed crackdown.46
Such operations are likely to be attractive to consumers seeking to purchase
so-called \lifestyle" drugs, such as those designed for weight loss, hair loss, or
erectile dysfunction.47 These drugs are potentially dangerous for certain pa-
tients.48 However, an online consultation avoids the inconvenience or embar-
rassment of consulting with a physician in person.49 Patients whose physicians
a website dispensing medication without a prescription \may not be a pharmacy at all").
45Typical unapproved drugs oered for sale online include GHB or GBL, the so-called date-
rape drugs. Id.
46These types of websites are the top priority for FDA enforcement eorts. Id. The phar-
macy industry also considers the \rogue pharmacies" to be those websites both prescribing
and dispensing within the same operation. See, e.g., Japsen, supra note 11.
47See Bendavid, supra note 39 (\These shady sites are generally powered not by the sale
of ordinary drugs, but by demand for such `lifestyle' drugs as Viagra for impotence, Propecia
for baldness and Xenical for weight loss."). A 1999 study by the University of Pennsylvania
documented 86 websites selling Viagra without a visit to a physician or a prescription. See
Kiefer, supra note 1.
48See Japsen, supra note 11 (relating how a fty-three-year-old Chicago man at risk of heart
disease died after taking the impotence pill Viagra he ordered through the Internet without
rst visiting a physician); Bendavid, supra note 39.
49See Working Group Report, supra note 4; Senate HELP Hearing, supra note 5 (state-
ment of Jane E. Henney, Food and Drug Administration Commissioner).
9have refused to issue prescriptions for desired medications may easily nd an
online pharmacy willing to sell them.
Accordingly, websites relying on online questionnaires or dispensing prescription
medication without a prescription pose a \signicant risk" to public health.50
First, transactions conducted in this manner occur outside the \traditional pro-
tections" of the doctor-patient relationship.51 Within this relationship, the risk
inherent in prescription drugs may be appropriately managed.52 Medications
are classied as prescription drugs for the very reason that they are deemed to
carry a sucient risk of side eects, interaction with other medications, or com-
plications caused by other ailments. The prescription system is meant to ensure
that a risky medication is not provided to a patient without the involvement of
a health care practitioner.
This involvement has traditionally included a physical examination of the pa-
tient and medical supervision. Patients traditionally are not expected (or en-
couraged) to make their own diagnoses and suggestions for medication.53 A
physician is relied upon to perform a physical examination because she has the
expertise to make a full diagnosis and conduct any tests deemed necessary. A
patient's personal physician can also compile the most accurate medical record
50Working Group Report, supra note 4,at Appendix D.
51See Senate HELP Hearing, supra note 5 (statement of Bruce A. Levy, Executive Director
of the Texas State Board of Medical Examiners) (\There is a lack of accountability and there's
health risks.").
52Senate HELP Hearing, supra note 5 (statement of Jane E. Henney, Food and Drug Ad-
ministration Commissioner).
53Working Group Report, supra note 4 (\[The Federal Food, Drug, and Cosmetic Act]
relies largely on two health professionals { a physician and a pharmacist { to protect patients
from the knowing or accidental misuse of medicines that are toxic or that have the potential
for causing harm.").
10and provide for follow-up.54
The \rogue" online pharmacies issue prescriptions in the absence of these mea-
sures. As a result, patients are more likely \to receive an inappropriate medi-
cation or to remain un- or misdiagnosed."55
A second stated failure of these particular categories of online pharmacy in terms
of public health is that consumers cannot easily conrm their legitimacy.56 For
instance, a customer can visit a traditional \brick-and-mortar" pharmacy or
doctor's oce, visually assess its facilities and sta, and generally assume that
the businesses will still be at that physical location the next day. Online phar-
macies, in contrast, may be located overseas, making it dicult or impossible
to enforce laws protecting consumers. Furthermore, the inability of consumers
to assess the legitimacy of an online pharmacy increases the risk that drugs are
placebos, mislabeled, or counterfeit.57
B.
Privacy of Consumer Information
The anonymity of the Internet, a characteristic that often helps attract those
54Senate HELP Hearing, supra note 5 (statement of Bruce A. Levy, Executive Director of
the Texas State Board of Medical Examiners).
55Senate HELP Hearing, supra note 5 (statement of Jane E. Henney, Food and Drug Ad-
ministration Commissioner). But see Kim Barker, Getting Prescription Drugs as Easy as Pie;
Louisiana Doctor Among Those with Web Pharmacies, New Orleans Times-Picayune, Jan.
30, 2000 (quoting Dr. Marcus Kuypers, a Dallas doctor licensed in Washington and working
with a Seattle online pharmacy: \There's lots of mills where you can go in to a doctor, and he
can take such an abbreviated history, you're in and out in two minutes....Is that safer than
something online? We review it in much greater detail. I'm taking 10 or 15 minutes with each
person.").
56Working Group Report, supra note 4,at Appendix D.
57See The White House, The Clinton Administration Unveils new Initiative to Protect
Consumers Buying Prescription Drug Products Over the Internet, December 28, 1999,
<http://www.fda.gov/oc/buyonline/onlinesalespr.html> (\Consumers who buy prescription
drugs online from illegitimate websites are at risk for adverse eects from inappropriately
prescribed medications, dangerous drug interactions, or contaminated drugs.").
11purchasing prescription drugs, threatens the privacy of consumer information:
\[S]ome online pharmacies might be nothing more than scams, collecting credit
card numbers and cash, but providing no products."58
V.
Combating \rogue" websites
A.
Adequacy of existing laws
1. Federal
Existing federal laws are generally adequate to cover the unlawful sale of
prescription drugs over the Internet.59 Under federal law, which applies to
prescription drugs sold in traditional \brick-and-mortar" pharmacies, by mail-
order pharmacies, or through telephone orders, the Internet may be considered
as just another means of communication.60
a)
Food, Drug, and Cosmetic Act
58Working Group Report, supra note 4, at Appendix D. See also Senate HELP Hearing,
supra note 5 (statement of Jane E. Henney, Food and Drug Administration Commissioner).
(\I think it's fair to say that consumers, particularly if they're using one of these more risky
sites..., leave themselves very vulnerable.").
59Working Group Report, supra note 4, at Appendix D. But see Senate HELP Hearing,
supra note 5 (statement of Senator Edward M. Kennedy) (\[E]xisting federal...laws have
had only limited success in protecting customers."). Senator Kennedy's observations might
be considered more accurately as critical of the current ability to enforce the laws, and not
necessarily the adequacy of the laws to cover the online activity at issue.
60Working Group Report, supra note 4, at Appendix D.
12The federal Food, Drug, and Cosmetic Act (\FDCA") prohibits the man-
ufacture and distribution of misbranded and adulterated drugs and requires
them to be labeled accurately. In addition, drugs must be manufactured and
handled so as to prevent contamination or misuse.61 Under the FDCA, drugs
categorized as prescription drugs may be dispensed only by the prescription of
a licensed practitioner.62
A prescription drug is \misbranded" if it is not dispensed on a valid prescrip-
tion.63 In addition, introduction or the delivery for introduction of a misbranded
drug into interstate commerce violates the FDCA.64 Both criminal and civil ac-
tions may be brought against individuals or companies dispensing misbranded
drugs (such as those dispensed without a valid prescription).65
Obviously, an online pharmacy dispensing prescription drugs without a valid
prescription is in violation of the FDCA.66 The online pharmacies purporting
to oer an online consultation before issuing a prescription and distributing the
prescription drugs are not in violation of 21 U.S.C. x 353(b) if they are issuing
a valid \prescription." What constitutes a valid prescription in cyberspace may
in fact depend upon state law.67 It has been suggested, however, that for a pre-
scription to be valid under 21 U.S.C. x 353(b) it must be issued in the context
of a \legitimate" doctor-patient relationship.68
61See 21 U.S.C. x 301 et seq.
62See 21 U.S.C. x 353.
63See 21 U.S.C. x 353(b)(1).
64See 21 U.S.C. x 331(a).
65See 21 U.S.C. x 333(a).
66See 21 U.S.C. x 353(b)(1).
67Working Group Report, supra note 4, at Appendix D.
68Id. (\For example, with the assistance of FDA, the Department of Justice has successfully
prosecuted doctors who `prescribed' steroids (which were regulated at the time as prescription
drugs, rather than controlled substances, as they are now) without establishing legitimate
13The Federation of State Medical Boards (\FSMB") has stated that physicians
who participate in an online operation where prescriptions are issued solely on
the basis of an electronic medical questionnaire fail to meet an acceptable stan-
dard of care.69 If such prescriptions are not valid as a matter of state or federal
law, then the online pharmacy may be found to be distributing \misbranded"
medication in violation of the FDCA.70
b)
Federal Trade Commission Act
Online pharmacies may also be regulated under the Federal Trade Com-
mission Act (\FTCA").71 Websites may be enjoined for engaging in unfair or
deceptive acts or practices, including false advertising of medications.72 Online
pharmacies making false or deceptive representations to potential consumers
are be in violation of the FTCA, making the website operator subject to a civil
enforcement action.73
c) Other federal statutes
Federal mail and wire fraud statutes are applicable if an online pharmacy
doctor-patient relationships with their customers.")
69Id.
70Id.
7115 U.S.C. x 45 et seq.
72See id. xx 45(a), 52
73Working Group Report, supra note 4, at Appendix D (\For instance, claiming that a
properly licensed physician will review the online questionnaire would be such a representation,
as would a representation that a product is safe. Websites may represent, falsely, that medical
information collected from consumers will be kept condential or that an online consultation
is equivalent to a physical examination.").
14defrauds a consumer.74 Also, related federal criminal and civil laws may be
implicated where an online pharmacy makes false representations to an insurer
to obtain payment.75
2. State
Some states, including Kansas, Missouri, Illinois, and Michigan, have sued
or plan to sue online pharmacies using state consumer protection acts.76 Such
suits claim that the act of prescribing and dispensing drugs over the Internet is
deceptive and unconscionable, in violation of the consumer protection act, where
neither the prescriber nor the dispensing pharmacy is licensed in the consumer's
state.77 Even in a successful suit, however, a given state can only aect the
operations of an online pharmacy in that state.78 States also have jurisdiction
over the licensing and regulation of physicians and prescribers operating within
the state.
B.
Enforcement challenges
74Id. (\Whether such a suit would be criminal or civil, under 18 U.S.C. x 1345 or the FDCA,
would depend on the precise facts of the case and the evidence of fraudulent intent.")
75Id. (\Some websites oer to bill private or public health care programs or insurers for a
`doctor's' advice or for the price of the drug or product itself.")
76See Senate HELP Hearing, supra note 5 (statement of Carla J. Stovall, Kansas Attorney
General).
77See Senate HELP Hearing, supra note 5 (statement of Carla J. Stovall, Kansas Attorney
General). Under Michigan's Consumer Protection Act, for example, \unfair, unconscionable,
or deceptive" practices in trade or commerce include \Causing a probability of confusion or
misunderstanding as to the source, sponsorship, approval, or certication of goods or services."
MCL x 445.903(1)(a) (1999).
78Accordingly, NAAG is asking Congress to provide for national injunctive relief. Senate
HELP Hearing, supra note 5 (statement of Carla J. Stovall, Kansas Attorney General).
15While applicable state and federal laws may be generally adequate, the In-
ternet presents new and signicant investigatory challenges for law enforcement
at all levels.79 In particular, the Internet introduces:
the need for real-time tracing of Internet communications across traditional
jurisdictional boundaries, both domestically and internationally; the need to
track down sophisticated users who commit unlawful acts on the Internet while
hiding their identities; the need for hand-in-glove coordination among various
law enforcement agencies; and the need for trained and well-equipped personnel
{ at federal, state, local, and global levels { to gather evidence, investigate, and
prosecute these cases.80
The coordination of enforcement eorts at state and federal levels is a partic-
ularly daunting task. Online pharmacies that oer an online diagnosis of med-
ical problems and provide prescriptions and distribution of prescription drugs
domestically are regulated by dierent federal and state agencies.81 Federal
statutes primarily regulate the illegal sale of prescription medications, but a
state has jurisdiction over the licensing and regulation of physicians and pre-
scribers operating within the state.82
State regulators face a challenge in investigating physicians oering online con-
sultations. First, state agencies face the potential diculty of identifying names,
locations, and any licensure or registration of the physicians and pharmacists
aliated with an online pharmacy. The time and resources necessary to pursue
enforcement actions against these individuals may become prohibitive if they
reside outside the state. Finally, a successful enforcement action against a given
online pharmacy does not prevent the website from providing online consulta-
79Working Group Report, supra note 4.
80Id.
81Id., at Appendix D.
82Id.
16tions and prescriptions drugs to consumers in other states.83
The issue of foreign-based online pharmacies has the most unanswered ques-
tions and poses the greatest challenge to U.S. law enforcement.84 The states
are completely dependent upon the federal government to prevent the illegal
importation of prescription drugs.85 Unfortunately, there are no international
laws upon which the United States and the Food and Drug Administration
(\FDA") can rely to take action against foreign operators.86 As a result, FDA
is dependent on the foreign country's cooperation in taking action against the
operator of an illicit website and otherwise enforcing U.S. laws pertaining to
prescription drugs.87
C.
Enforcement actions
1. Federal
As a result of new enforcement measures, by March 2000 FDA had more
than 40 sites being actively reviewed for possible regulatory or civil action. In
addition, FDA had sent 23 warning letters to domestic online drug sellers and
83Working Group Report, supra note 4, at Appendix D.
84Senate HELP Hearing, supra note 5 (statement of John Taylor, senior adviser of the
Oce of Regulatory Aairs of the Food and Drug Administration).
85Senate HELP Hearing, supra note 5 (statement of Carla J. Stovall, Kansas Attorney
General) (\We would appreciate aggressive enforcement of overseas companies by the DEA
and Customs and others that can do that beyond what we can.").
86Senate HELP Hearing, supra note 5 (statement of Jane E. Henney, Food and Drug Ad-
ministration Commissioner).
87Senate HELP Hearing, supra note 5 (statement of John Taylor, senior adviser of the
Oce of Regulatory Aairs of the Food and Drug Administration).
17transmitted \cyber letters" to thirteen operators of foreign-based websites of-
fering prescription drugs for sale online.88 An injunction was imposed on one
product and others were being considered, including some for unapproved ther-
apies being oered online.89
In the year preceding the hearing, FDA also conducted eight product seizures,
issued six product recalls, and incited the voluntary destruction of seven viola-
tive products.90
With respect to actions taken against suspected criminal activity, FDA Oce
of Criminal Investigations currently has at least 134 open investigations of web-
sites selling prescription drugs, providing unapproved products, or committing
various types of health fraud.91 FDA also reported 36 arrests and 17 convictions
related to the sale of drugs over the Internet.92
In another approach, the U.S. Customs Service's CyberSmuggling Center is
working with Customs attach e oces to identify and target foreign-based on-
line pharmacies that are shipping prescription drugs and controlled substances
into the United States.93 FDA does work with the U.S. Customs Service to try
and prevent illegal pharmaceutical products from entering the United States,94
88Id.
89The product against which an injunction has been imposed contains a \potent thyroid
hormone" and was marketed as a weight loss aid. Senate HELP Hearing, supra note 5
(statement of John Taylor, senior adviser of the Oce of Regulatory Aairs of the Food and
Drug Administration).
90Id.
91As of March 21, 2000. Fifty-four of the 134 investigations are of websites selling prescrip-
tion drugs. The other 80 investigations are of websites committing health fraud or oering
unapproved products for sale. Id.
92Id.
93Working Group Report, supra note 4, at Appendix D.
94U.S. Customs Service reported a 450% increase in the number of seizures of illegal phar-
maceutical products from 1999, an increase attributed directly to Internet sales. Senate HELP
Hearing, supra note 5 (statement of Senator James M. Jeords).
18and has expressed its dedication to assisting Customs in detecting illegal prod-
ucts purchased online.95
2. State
A small but growing number of states have taken action against illegal online
pharmacies. As noted above, some states, have sued or plan to sue online
pharmacies using state consumer protection acts.96 In addition, at least twelve
states have taken action against physicians for prescribing violations related to
online pharmacies.97
D.
Initiatives
1.
95Senate HELP Hearing, supra note 5 (statement of John Taylor, senior adviser of the
Oce of Regulatory Aairs of the Food and Drug Administration).
96For example, in December 1999, Michigan issued cease-and-desist order to ten online
pharmacies. See Japsen, supra note 11. New Jersey sued eight out-of-state online pharmacies
(whose websites included viagralov-making.com, ez-diet-products.com, and anydrugs.net) in
March 2000 under its Consumer Fraud Act for failing to disclose they were not licensed
to dispense drugs or practice medicine in the state. See Kevin G. Demarrais, New Jersey
Accuses Online Drugstores of Selling Medications Illegally, Knight-Ridder Tribune Bus.
News, Mar. 31, 2000.
97At the time of the Senate HELP Hearing, they included California, Colorado, Florida,
Hawaii, Illinois, Michigan, Missouri, Nevada, Ohio, Washington, Wisconsin, and Wyoming.
Senate HELP Hearing, supra note 5 (statement of Bruce A. Levy, Executive Director of the
Texas State Board of Medical Examiners). For example, the Illinois Department of Profes-
sional Regulation ned an Illinois doctor and placed him on two years of probation for writing
prescriptions over the Internet without physically examining the patients. Bendavid, supra
note 39. The Illinois physician, Robert Filice, issued a statement in response to the state
action, saying that he was guilty only of \being a pioneer in a new and unexplored area."
Postrel, supra note 3. Arizona's Board of Osteopathic Examiners also recently restricted the
licenses of three osteopaths for prescribing Viagra and other lifestyle-changing drugs on the
Internet without properly examining patients and recording their medical histories. See Della
de Lafuente, Online Drugstores Under Scrutiny, Arizona Republic, Apr 30, 2000.
19Federal initiatives
The House Oversight Hearing in July 1999 before the U.S. House of Repre-
sentatives Senate Committee, Subcommittee on Oversight and Investigations,98
was the rst widely publicized government response to online pharmacies. In-
vestigative journalists and representatives from online pharmacies, federal agen-
cies, national medical and pharmacy associations, and state law enforcement
presented testimony on the issues and problems related to online pharmacies.
Also in July 1999, FTC suggested that websites oering prescription drugs
be required to disclose certain information about the pharmacy dispensing the
medication, the states where the pharmacy is licensed to operate, personal in-
formation about the physicians providing prescriptions online, and the states to
which the website will distribute prescription drugs.99
In August 1999, President Clinton issued an executive order establishing the
President's Working Group on Unlawful Conduct on the Internet (\Working
Group").100 The Working Group was given the task of studying unlawful ac-
tivity taking place on the Internet, including the unlawful sale of prescription
drugs.101 It released its report (\Working Group Report") on March 9, 2000.102
Also in August 1999, Congressman Ronald Klink (D-PA) introduced the In-
ternet Pharmacy Consumer Protection Act, H.R. 2763, which would require
98House Oversight Hearing, supra note 5.
99Working Group Report, supra note 4, at Appendix D.
100Exec. Order No. 13,133, supra note 4.
101Id.
102Working Group Report, supra note 4.
20online pharmacies to provide identifying information on their websites and au-
thorize FDA to enforce the requirements. 103 In February 2000, Representative
Ronald Paul (R-TX) introduced H.R. 3636,104 which included an amendment
to FDCA Section 503(b).105 The amendment simply claries the applicability
of the FDCA to prescription drug purchases made through the Internet, but
it would also prohibit the FDA from taking action against an Internet website
for prescription drug sales, so long as the sale complied with the FDCA and
applicable state law and the website displayed information regarding its com-
pliance.106
Before the Working Group Report was released, the Clinton Administration
issued a policy initiative in a \Statement Announcing Zero Tolerance for Pre-
scription Drug Internet Sites Harmful to Patient Safety and Health."107 The
December 1999 initiative proposed sti civil penalties for \rogue operators" of
pharmacy websites, a mandatory federal pre-approval scheme, and a $10 million
budget to fund FDA monitoring eorts.108
A well-publicized hearing before the Senate Health, Education, Labor and Pen-
sions (\HELP") Committee in March 2000 addressed the issue of how to develop
a comprehensive scheme to regulate online pharmacies.109 Many of the same
representatives who testied at the House Oversight Hearing were in attendance.
In the short time between the two Congressional hearings, however, several ac-
103H.R. 2763, 106th Cong. (1999).
104H.R. 3636, 106th Cong. (1999).
10521 U.S.C. 353(b).
106H.R. 3636, 106th Cong. (1999).
10735 Weekly Comp. Pres. Doc. 2677.
108Id.
109Senate HELP Hearing, supra note 5.
21tions, described above, had been taken by law enforcement at both the state
and federal levels. While acknowledging the diculty of drafting legislation that
will ensure the protection of the public health without stiing online business,
HELP Committee member Senator Christopher Dodd concluded: \I think what
is very clear is that doing nothing is not an option."110 FDA Commissioner Jane
Henney agreed that the consequences of government inaction or delay in the face
of these challenges could include adverse side eects or loss of life.111
By the time of the Senate HELP Hearing, FDA had taken several steps to pre-
vent illegal sales of pharmaceuticals online. First, FDA prioritized the greatest
public health threats posed by unregulated online pharmacies: sales of unap-
proved new drugs,112 health fraud, and prescription drugs sold without a pre-
scription.113 Second, FDA improved its technology and ability to monitor the
Internet and acquire information on potentially violative sites.114
FDA also coordinated a \triage team" for case assessment. The team, which
includes representatives from dierent key government agencies, is responsible
for analyzing information and determining if any enforcement measures need
110At the same time, Dodd cautioned that the fact a hearing was being held on the \serious"
and \growing" issue does not indicate that the problem is \endemic." In fact, Dodd claimed,
\the overwhelming majority of pharmacies do their business properly and well." Senate HELP
Hearing, supra note 5 (statement of Senator Christopher J. Dodd).
111Senate HELP Hearing, supra note 5 (statement of Jane E. Henney, Food and Drug Ad-
ministration Commissioner).
112Some of the products FDA is most concerned about include illegal drugs like GHB, drugs
designed to treat seizures, hormones, drugs designed to treat prosthetic hypertrophy, and
generally drugs that should not be used without a physician's supervision. See Senate HELP
Hearing, supra note 5 (statement of Janet Woodcock, Director of the Center for Drug Evalu-
ation and Research of the Food and Drug Administration).
113Senate HELP Hearing, supra note 5 (statement of John Taylor, senior adviser of the
Oce of Regulatory Aairs of the Food and Drug Administration).
114Senate HELP Hearing, supra note 5 (statement of John Taylor, senior adviser of the
Oce of Regulatory Aairs of the Food and Drug Administration).
22to be taken.115 FDA also signed agreements with the National Association of
Boards of Pharmacy (\NABP") and FSMB to work together to address the
issue of illegal online prescription drug sales.116 According to FDA, the \team
eort has eliminated overlap, increased communications and streamlined the
overall enforcement process."117
FDA has taken further steps to improve consumer education. Education is
viewed as a critical component in the war against the illegal sale of prescription
drugs over the Internet.118 At the Senate HELP Hearing, Senator Dodd sug-
gested that consumers are not as careful when shopping online as when shopping
oine: \Too often we assume that simply because a business has a web site,
it must be legitimate."119 To address this, FDA has created a website with
recommendations about making purchases online.120
2.
115Id.
116See Henkel, supra note 3.
117Senate HELP Hearing, supra note 5 (statement of John Taylor, senior adviser of the
Oce of Regulatory Aairs of the Food and Drug Administration).
118But there is some uncertainty as to the best approach to consumer education. During the
Senate HELP Hearing, Senator Dodd asked FDA representatives why FDA has not posted
a list of domestic websites on the FDA website (www.fda.gov) that the FDA has eectively
\condemned" for their online activities. Senate HELP Hearing, supra note 5 (statement
of Senator Christopher J. Dodd). FDA has instead taken an \opposite tack," focusing its
education eorts on providing information about the harms of particular products oered
online and how consumers can identify legitimate online pharmacies. Senate HELP Hearing,
supra note 5 (statement of Jane E. Henney, Food and Drug Administration Commissioner).
FDA representatives at the Senate HELP Hearing also expressed a reluctance to condemn a
domestic website in the manner suggested by Senator Dodd precisely because of the diculties
faced in investigating and inquiring information about suspected websites; websites \are very
hard to tease apart." Id. (\[W]e certainly don't want to be wrong).
119Senate HELP Hearing, supra note 5 (statement of Senator Christopher J. Dodd).
120The website also contains information about the Clinton Administration initiative, en-
forcement actions taken by FDA against online pharmacies, and testimony of FDA ocials.
See U.S. Food and Drug Administration, Buying Medical Products Online, visited on April
29, 2000) <http://www.fda.gov/oc/buyonline/default.htm> (\Here's information on how you
can take advantage of the convenience and privacy of online buying while still protecting your
health and your money.").
23State-based initiatives
To address the issue of \rogue" pharmacy websites, at least nine states have
adopted rules or statements clarifying standards for online prescription and dis-
pensing of medications.121 Five states have introduced legislation establishing
the practice standards for prescribing drugs through the Internet.122
In addition, the Special Committee on Professional Conduct and Ethics of
FSMB has recommended that state medical boards \consider it unprofessional
conduct by a physician, subject to disciplinary action, to provide treatment rec-
ommendations, including issuing a prescription via electronic or other means,
unless the physician has performed a history and physical examination of the
patient adequate to establish diagnosis and identify underlying conditions or
contraindications to this treatment."123
To encourage the disclosure by online pharmacies of information about their
corporation, licensure, and pharmacists, NABP has created the Veried Internet
Pharmacy Practice Sites (\VIPPS") program. Only ve pharmacy websites
have as yet qualied for the VIPPS \seal of approval" for meeting the program's
criteria, which include compliance with state law and voluntary compliance with
121Alabama, California, Florida, Maryland, Missouri, Nevada, North Carolina, Ohio, and
Texas. Senate HELP Hearing, supra note 5 (statement of Bruce A. Levy, Executive Director
of the Texas State Board of Medical Examiners).
122Arizona, California, Florida, Kansas, and Virginia. Senate HELP Hearing, supra note
5 (statement of Bruce A. Levy, Executive Director of the Texas State Board of Medical
Examiners).
123Senate HELP Hearing, supra note 5 (statement of Bruce A. Levy, Executive Director of
the Texas State Board of Medical Examiners).
24requirements developed by NABP.124
VI.
Proposals and criticisms
The proposals that follow all contain measures designed to combat the law
enforcement challenges described above. Most contributors to this issue agree
that coordination of law enforcement eorts is required, and that additional
funding is required to monitor the Internet for oenders. Most also agree that
consumer education is very important so that patients are discouraged from pa-
tronizing \rogue" online pharmacies. While existing federal law and state law
may be adequate to regulate online pharmacies, there is general agreement that
some steps must be taken to ensure that online pharmacies make disclosures or
obtain appropriate certications. As a complement to existing laws, such dis-
closures would oer to consumers the same verication of legitimacy that exists
in the oine world, so that they can distinguish legitimate websites from the
\rogue" ones.125 The controversy, of course, is over who should regulate the
disclosures.
The White House \zero tolerance" initiative focuses on increasing the existing
civil penalties for illegal prescription drug sales and improving the resources
124The recipient websites are drugstore.com, cvs.com, PlanetRx.com, medco.com, and fam-
ilymeds.com. Senate HELP Hearing, supra note 5 (statement of Carmen A. Catizone, Exec-
utive Director of the National Association of Boards of Pharmacies).
125Working Group Report, supra note 4, at Appendix D. (\Consumers are assured of
the safety and suitability of the drugs that they take not only because the drugs must be
prescribed by a licensed physician, but also because they must be dispensed by a licensed
pharmacy.")
25available to combat illegal activity online.126 For instance, the initiative seeks
to give FDA administrative subpoena authority, which would enable FDA to
investigate violative websites faster and more eciently.127 The initiative also
proposes a public education eort aimed at consumers.
Finally, and most controversially, the White House initiative suggests establish-
ing new federal requirements specically for online pharmacies.128 The White
House initiative requires that online pharmacies seek FDA approval before oer-
ing online services. The pre-approval process would ensure that online pharma-
cies comply with all relevant state and federal laws.129 All pharmacy websites
meeting the requirements would be allowed to display a visual indicator, such
as a seal of approval, that consumers could look for when shopping online.130
The rationale behind the White House proposal is that while states have tra-
ditionally handled the regulation of pharmacies very well, a federal system of
126Civil money penalties would increase to a maximum of $500,000. Also, to fund
FDA investigative eorts in routinely checking for illegal Internet sites, the initiative is
proposing that $10 million in new funds be allocated for scal year 2001. See U.S.
Food and Drug Administration, Online Pharmacies FAQs, last modied January 27, 2000
<http://www.fda.gov/oc/buyonline/prfaqs.html> (\[T]he proposal provides for civil money
penalties for the illegal sale of prescription drugs. Depending on the nature and severity of
the violation, a person may face up to $500,000 in civil money penalties and/or criminal
sanctions.").
127Id. (\To obtain records needed for investigating suspect Websites, FDA has often had
to rely on the issuance of grand jury subpoenas. This is a time-consuming process that has
led to unnecessary delays in investigating potentially illegal Websites. The authority being
proposed is limited in scope, but would allow FDA to acquire certain information by obtaining
a subpoena administratively, thus saving precious investigative time.").
128The Administration plan focuses primarily on prescription drugs. Whether other FDA-
regulated products (over-the-counter drugs, medical devices, etc.) will be covered is still being
worked out for the legislative proposal. Id.
129Appendix D (\These requirements, the details of which are undergoing interagency re-
view, might include disclosures or certications regarding the identity of pharmacists or other
relevant health care professionals employed by the website and the states in which they are
licensed.")
130Participation in the regulatory program will be mandatory, in contrast with the Veri-
ed Internet Pharmacy Practice Sites (VIPPS) program directed by National Association of
Boards of Pharmacy (NABP). See U.S. Food and Drug Administration, Online Pharmacies
FAQs, supra note 126.
26credentials for Internet pharmacies is necessary to regulate the rapidly growing
number of online pharmacies.131 The current regulatory scheme is based on
the model of a patient visiting a local doctor or hospital, having a physician
issue a prescription, and then lling the prescription at a pharmacy. Supporters
of federal regulation of online pharmacies argue that the traditional model is
outdated and that the laws must change to address the reality of how illegal
online pharmacies operate in cyberspace.132 State investigators simply do not
have the resources available to regulate a multiplying number of multistate op-
erations and still provide the same level of protection that exists in the system
of traditional \brick-and-mortar" pharmacies.
In any case, according to FDA representatives, the Clinton Administration ini-
tiative is not designed to preempt any state laws or encourage FDA to take
more actions on its own without state involvement.133 FDA does not intend to
change the \long-standing policy" of working closely with state authorities \on
issues that impact the practice of pharmacy or the practice of medicine, which
have traditionally been regulated by the states."134 FDA would only step in if
state action proves insucient.135
It is hoped by FDA Commissioner Henney that the legislative resolution of any
potential jurisdictional problems would be aided by the common goal of pro-
131See, e.g., Adams, supra note 2.
132Bendavid, supra note 39 (quoting FDA spokesman Bill Hubbard: \A site in Arizona
selling to 40 other states may not be something ocials in Arizona care about. And ocials
in the 40 other states may have no way to get at it. You need a law that ts the crime, and
current law does not t the crime.")
133See U.S. Food and Drug Administration, Online Pharmacies FAQs, supra note 126.
134See id.
135Bendavid, supra note 39. Hubbard insisted that \brick-and-mortar" pharmacies would
feel no eect from the proposed measures. Id.
27tecting the health of patients and consumers: \[I]t's really all about outcome
here."136 The message being presented by FDA and the Clinton Administration
is crafted so the traditional authority of the states in these matters is recognized
and lauded. In this spirit, Henney suggested that \what we're striving for here
is a safety net for the [online] that is strong as any that works within any
state's borders."137 The White House proposal, Henney said, \will be heavily
reliant on what states have traditionally done, both through their enforcement
[and] through the oversight of the practices in medicine and pharmacy in those
states."138
FDA highlights the cooperative nature of its approach thus far, pointing to the
formal agreements reached with NABP and FSMB and its work with NAAG.139
FDA acknowledges that is has authority in the areas of the practice of pharmacy
or the practice of medicine, but claims that it would continue to rely upon the
state licensing and regulatory boards for enforcement actions.140
There is evidence that eorts can be coordinated without generating crippling
interjurisdictional squabbles. The Working Group Report highlights an alliance
of the Kansas Attorney General's Oce and the U.S. Attorney's Oce for the
District of Kansas that was formed in August 1999. The federal-state coalition
included representatives from the Kansas Pharmacy Board, Kansas Board of
Healing Arts, Consumer Protection Division, the Medicaid Fraud and Abuse
136Senate HELP Hearing, supra note 5 (statement of Jane E. Henney, Food and Drug Ad-
ministration Commissioner).
137Id.
138Id.
139See U.S. Food and Drug Administration, Online Pharmacies FAQs, supra note 126.
140Id.
28Division, and the Food and Drug Administration's Oce of Criminal Investiga-
tions.141
The state authorities are charged with identifying online pharmacies that may
not meet state regulations but are attempting to oer legitimate pharmaceutical
services. According to the Working Group, Kansas authorities have found that
once notied, such operations will generally conform their conduct to meet state
regulations.142 The U.S. Attorney's Oce main role is the identication of in-
dividuals responsible for illegal online pharmacy websites. Kansas state ocials
then take legal action against those physicians, prescribers, website operators,
or pharmacies responsible for dispensing prescription drugs over the Internet in
violation of Kansas state law (i.e., where \prescriptions" issued based solely on
online consultations are deemed invalid").143
But if cooperative law enforcement eorts can work, is federal pre-approval of
online pharmacies necessary? The states do not necessarily believe that the fed-
eral government should step in to regulate online pharmacies because website
operations may cross state boundaries.144 State law enforcement representa-
tives at the Congressional hearings have been adamant about continuing their
traditional role as the primary enforcement authority in regulating pharmacies,
physicians, and generally businesses and professions that operate via the Inter-
net. With regard to the White House proposal for requiring pre-approval of
pharmacies operating online, NAAG thinks that \is a path better left untrav-
141Working Group Report, supra note 4, at Appendix D.
142Id.
143Working Group Report, supra note 4, at Appendix D.
144Senate HELP Hearing, supra note 5 (statement of Carla J. Stovall, Kansas Attorney
General).
29eled."145
The states are fully aware, however, of their limitations in addressing the issue
\rogue" online pharmacies. As discussed above, even if a state is successful
in enjoining a targeted online pharmacy from conducting operations in that
state, the website may continue operating in other states. Those other states
would have to seek their own injunctions. To avoid this unnecessary duplica-
tion of scarce state resources, NAAG has asked Congress to provide for national
injunctive relief.146 With national injunctive relief, a state acting in its tradi-
tional role to protect the health of its own citizens could secure an injunction
in a federal district court and also enjoin the illegitimate online pharmacy from
operating throughout the United States.147 At the same time, NAAG wants
Congress to provide disclosure requirements in order to aid state law enforce-
ment.148
FSMB believes that current laws are adequate, \but strict and aggressive en-
forcement must be encouraged."149 FSMB feels that the most appropriate
involvement of the federal government is in this area of \aggressive enforce-
ment."150 In an eort to meet the investigative challenges faced by states,
FSMB plans to establish a central \clearinghouse" for information regarding
the operation of suspected pharmacy websites that could be accessed by all
145Id.
146Id.
147Id.
148Id. (\The diculty that states [have] in going after these folks is to get through the
multiple layers of shell corporations to get to the fake addresses, the dierent layers that are
involved to try to hide the true identities.").
149Senate HELP Hearing, supra note 5 (statement of Bruce A. Levy, Executive Director of
the Texas State Board of Medical Examiners).
150Id.
30state medical boards.151
Reaction to the Clinton Administration's initiative from the industry was mixed.152
Pharmacy groups expressed their belief that any additional regulation by FDA
would create an unnecessary barrier to electronic commerce.153 Fearing in-
creased regulation by FDA, the industry felt that the states, which were already
involved in investigating suspect Internet websites, should be allowed to con-
tinue in their traditional role of regulating pharmacies.154 Some industry groups
also feared that special measures created for the Internet could eventually lead
to similar regulation of mail-order pharmacies.155
Some retail pharmacies and mail-order drug rms, however, expressed approval
of Administration's proposal to require online pharmacies to get federal approval
before dispensing medications online.156 Some major retail pharmacies would
prefer federal regulation of their online operations because it might bolster con-
sumer condence in the pharmacy industry generally.157
The National Association of Chain Drug Stores (\NACDS") expressed its ap-
proval of the Administration's goal, but supports the continuation of NABP's
voluntary VIPPS program.158 It contends that voluntary measures like VIPPS,
151Id.
152See, e.g., Adams, supra note 2.
153See id. (quoting Susan Winckler, a policy director for the American Pharmaceutical
Association: \I don't know that the FDA jumping in and regulating will bring any benet.
It will just confuse the situation."). Shares in some online drugstore companies dropped in
response to the proposed increase in federal oversight. See id.
154See id.
155See id.
156See Bruce Japsen, supra note 11 (quoting David Joyner, senior vice president of sales and
marketing for the prescription division of Caremark Rx Inc.: \We're in line with Clinton on
this.").
157Id. (quoting Michael Polzin, spokesman for Walgreen Co.: \It doesn't overly concern us
that the FDA would be looking to get involved. But we would like to work with them to draft
their standards.").
158See Sherman Fridman, NACDS Urges Caution in Internet Drug Regulation, Newsbytes
31when coupled with NABP oversight and more aggressive enforcement of al-
ready existing regulations by FDA, state boards of pharmacy, and state boards
of medicine, are adequate to protect consumers \without the expansion of the
FDA's authority over the legitimate practice of pharmacy."159
On the other hand, the National Community Pharmacists Association (\NCPA")
supports a federal requirement that all Internet pharmacies verify and also dis-
close on their websites their state licensure and the licensure of their pharma-
cists.160 NCPA also supports penalties for pharmacies and pharmacists selling
prescription medication without a valid prescription.161 A \signicant" new
initiative is not necessary, however. Instead, NCPA recommends that existing
laws be used in conjunction with cooperative eorts by state and federal agen-
cies.162
One area in which there is little direction concerns how the United States should
address the issue of prescription drugs being imported illegally from abroad.
Notably, there is no specic mention of foreign-based websites in the White
House proposal. One avenue of attack may be to rely more heavily on the for-
eign counterparts to the U.S. Customs Service and FDA to deal with online
prescription rms in other countries.163 Unfortunately, the \philosophical dif-
ferences between countries on combating the sale of illegal goods online" often
thwart eorts at such cooperation.164
News Network, available at 1999 WL 29944400, December 29, 1999.
159Id. (quoting Craig L. Fuller, president and chief executive ocer of NACDS).
160Senate HELP Hearing, supra note 5 (statement of Calvin A. Anthony, executive vice
president of National Community Pharmacists Association).
161Id.
162Id.
163Working Group Report, supra note 4, at Appendix D.
164Id.
32However, while many parcels entering the United States are being seized by
the Customs Service,165 \the Customs Service and the FDA would require a
substantial increase in resources and personnel as a practical matter to stop all,
or even most, illegal prescription drugs from entering the country."166 The $10
million in new funding requested in the White House initiative for scal year
2001 likely would not be applied by FDA to eorts like interception of illegally
imported drugs.167
In another approach, NABP is trying to convince some other countries to adopt
VIPPS program in order to create \an international safety net" for consumers
of prescriptions drugs online.168
Finally, to complicate the matter further, some commentators anticipate that
successful regulation and enforcement eorts domestically will merely force ille-
gitimate operations abroad.169
VII.
Conclusion
The recent media and Congressional attention given to the issue of illegal
165See Working Group Report, supra note 4, at Appendix D. (\Upon a determination by
FDA that the drugs are in violation of law, the parcels are seized and referred for investigative
follow-up. The Customs Service seized 9,725 packages with prescription drugs last year, over
four times as many as were seized in 1998."
166Id.
167The funding is apparently to be allocated for sta and resources necessary to monitor
domestic websites. Senate HELP Hearing, supra note 5 (statement of Jane E. Henney, Food
and Drug Administration Commissioner) (\In terms of working the foreign issue in specic,
that [requested funding] would not permit us to totally increase that eort. Again, we're
highly reliant on the relationships that we've got with other countries if we're going to be
eective in that area.").
168Senate HELP Hearing, supra note 5 (statement of Carla J. Stovall, Kansas Attorney
General).
169See id.
33sales of prescription drugs online highlight the threat to public health posed by
\rogue" online pharmacies and the challenges faced by state and federal law
enforcement. State and federal agencies are starting to coordinate their eorts
and will likely improve this approach over time. Some states, though limited in
nancial and technological resources, have taken action against \rogue" phar-
macies. All parties to the issue seem to agree that disclosure is the key to
establishing and arming the legitimacy of pharmacy websites, but the terms
of a disclosure program still need to be worked out. The biggest challenge in
regulating the illegal sale of prescription drugs online remains the issue of how to
address the fact that many of the \rogue" online pharmacies are foreign-based.
FDA Commissioner Henney characterized the required response to the threat
to public health as \a long-haul eort." At the Senate HELP Hearing, Henney
reiterated FDA's dedication to the project and said FDA is attempting \to en-
gage all parties that have an interest in making this work right for the American
public," including state boards of healing arts, state boards of pharmacy, and
state attorneys general.170 Still, FDA representatives and committee members
both expressed concern that the level of issue focus and priority represented by
the Working Group report and the Senate HELP Hearing would fade.171
170Senate HELP Hearing, supra note 5 (statement of Jane E. Henney, Food and Drug Ad-
ministration Commissioner).
171See, e.g., Senate HELP Hearing, supra note 5 (statement of Senator Christopher J. Dodd)
(\A lot of times these reports, they end up { they're wonderful reports, they end up sitting
on a shelf, obviously, as we've seen far too often."). The concern may be well-founded.
On May 2, 2000, the White House sent a bill containing the details of its \zero tolerance"
policy to Congress without fanfare and with little media attention. See Reaction Mixed To
Administration Bill On Web Drug Sales, National Journal's CongressDaily, May 4, 2000.
34